A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

被引:0
作者
Jordi Rodon
Charlotte D. Jacobs
Quincy Chu
Eric K. Rowinsky
Arturo Lopez-Anaya
Chris H. Takimoto
Heather A. Wakelee
机构
[1] Cancer Therapy and Research Center at The University of Texas Health Science Center,Institute for Drug Development
[2] Stanford University and Stanford Cancer Institute,Division of Oncology, Department of Medicine
[3] Eisai,undefined
[4] Inc.,undefined
[5] Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology,undefined
[6] Cross Cancer Institute,undefined
[7] University of Alberta,undefined
[8] Oncodrugs Consulting,undefined
[9] Forest Laboratories,undefined
[10] Inc.,undefined
[11] Ortho Biotech Oncology R&D/Johnson & Johnson,undefined
来源
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词
Bexarotene; Carboplatin; Paclitaxel; Pharmacokinetics; Phase I;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:825 / 834
页数:9
相关论文
共 280 条
  • [61] Fenaux P(undefined)undefined undefined undefined undefined-undefined
  • [62] Le Deley MC(undefined)undefined undefined undefined undefined-undefined
  • [63] Castaigne S(undefined)undefined undefined undefined undefined-undefined
  • [64] Archimbaud E(undefined)undefined undefined undefined undefined-undefined
  • [65] Chomienne C(undefined)undefined undefined undefined undefined-undefined
  • [66] Link H(undefined)undefined undefined undefined undefined-undefined
  • [67] Guerci A(undefined)undefined undefined undefined undefined-undefined
  • [68] Duarte M(undefined)undefined undefined undefined undefined-undefined
  • [69] Daniel MT(undefined)undefined undefined undefined undefined-undefined
  • [70] Bowen D(undefined)undefined undefined undefined undefined-undefined